SBI Life Insurance Company Limited (SBILIFE)
₹1,656.80 -0.30% last close, 16 Oct
Q2 FY27 results
📅 Next results: 27 Oct 2026 (board meeting)SBI Life Insurance Company Limited's board meets on 27 Oct 2026 to consider its Q2 FY27 results (July-September 2026).
In its latest reported quarter, Q4 FY26, SBI Life's revenue was ₹4,071 Cr (-82.4% year on year, -91.2% on the previous quarter), and net profit ₹805 Cr (-1.1% year on year); the operating margin was -25.7%.
| Q4 FY26 (₹ Cr) | Value | YoY vs Q4 FY25 | QoQ |
|---|---|---|---|
| Revenue | ₹4,071 | -82.4% | -91.2% |
| Operating profit | ₹-1,046 | loss widened | to loss |
| Net profit | ₹805 | -1.1% | +39.5% |
| EPS (₹) | 8.02 | -1.2% | +39.5% |
| Operating margin | -25.7% | — | — |
SBILIFE delivery percentage, bulk deals and open interest
NSE end-of-day data for
On Fri, 16 Oct 2026, 70.31% of the SBILIFE shares traded on NSE were taken to delivery, against the stock's own 20-session average of 61.1%. Delivery was unusually high while the price barely moved (-0.30%). It traded 2.1 times its average daily volume. In SBILIFE futures, open interest rose 2.78% while the futures price fell 0.55%: short buildup (new short positions). 2 bulk or block deals were reported in SBILIFE in the last 60 days: ₹107 Cr bought and ₹107 Cr sold.
Delivery in the last 5 sessions: 62.3% · 63.8% · 57.8% · 60.2% · 70.3%
| Date | Side | Counterparty | Value | Price | Quantity | Type |
|---|---|---|---|---|---|---|
| 8 Oct | Sell | Pioneer Investment Fund Scheme Ii | ₹107.30 Cr | ₹1,671.00 | 642,153 | Block |
| 8 Oct | Buy | Pi Opportunities Aif V Llp | ₹107.30 Cr | ₹1,671.00 | 642,153 | Block |
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
SBI Life Insurance Company Limited has submitted its confirmation certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The company's Registrar and Share Transfer Agent, KFin Technologies Limited, confirmed that 100% of the company's securities are held in dematerialized form. Furthermore, zero requests for rematerialization were received during the quarter. This is a recurring administrative compliance filing with no impact on business operations or financials.
- Compliance certificate submitted under Regulation 74(5) for the quarter ended September 30, 2026
- RTA KFin Technologies confirmed all securities are held in dematerialized form
- 0 requests received for rematerialization of securities during the quarter
SBI Life Insurance Company Limited received an order under Section 74 of the RGST Act, 2017, from the Deputy Commissioner, Zone-Jaipur I, Rajasthan. The total demand amounts to ₹1,12,99,508, comprising ₹96,12,911 in tax, ₹7,25,306 in interest, and a penalty of ₹9,61,291. The issue relates to alleged excess Input Tax Credit claimed in GSTR-3B versus GSTR-2B for the period April 2025 to August 2025. The company intends to appeal the order before the competent appellate authority, and the financial impact is negligible relative to its FY26 PAT of ₹2,471 crore.
- Total demand raised stands at ₹1,12,99,508, including penalty and interest
- Demand consists of ₹96,12,911 in tax and ₹7,25,306 in interest
- Penalty imposed amounts to ₹9,61,291 under Section 74 of the RGST Act, 2017
- Communication pertains to excess Input Tax Credit mismatch for April 2025 to August 2025
SBI Life Insurance has announced the appointment of Mr. Nihar Niranjan Jambusaria as an Additional Independent Director, effective September 22, 2026. The appointment has been made for a consecutive tenure of 3 years and is not subject to retirement by rotation. Mr. Jambusaria is a chartered accountant and former President of ICAI with over four decades of tax and finance expertise. This is a routine board-level corporate governance enhancement with no direct impact on financials.
- Appointment of Mr. Nihar Niranjan Jambusaria as Additional Independent Director effective September 22, 2026
- Appointed for a term of 3 consecutive years, not liable to retire by rotation
- Board meeting commenced at 06:45 P.M. and concluded at 07:00 P.M. on September 22, 2026
- Appointee brings over 40 years of experience in direct tax, international tax, and finance
SBI Life Insurance Company Limited announced the allotment of 55,501 equity shares of face value Rs. 10 each following the exercise of vested stock options under its ESOS 2018 scheme. The allotment was approved by the Board Stakeholders' Relationship & Sustainability Committee on September 17, 2026. Following this issue, the company's paid-up share capital increased marginally to Rs. 10,03,40,50,730, comprising 1,00,34,05,073 equity shares. The equity dilution resulting from this allotment is negligible.
- Allotted 55,501 equity shares of Rs. 10 face value under ESOS 2018
- Paid-up share capital increased to Rs. 10,03,40,50,730
- Total post-allotment share count stands at 1,00,34,05,073 equity shares
- Resolution approved by the Board Stakeholders' Relationship & Sustainability Committee on September 17, 2026
SBI Life Insurance Company Limited announced that M/s. K S Aiyar & Co. and M/s. J Singh & Associates have accepted reappointment as Joint Statutory Auditors for FY 2026-27. This follows an appointment letter dated September 09, 2026, issued by the Comptroller & Auditor General of India (C&AG). Both audit firms will continue their statutory audit functions for the company under Section 139 of the Companies Act, 2013. The announcement is a routine statutory compliance matter with no impact on business operations or financials.
- C&AG letter dated September 09, 2026, issued for appointment of Joint Statutory Auditors
- M/s. K S Aiyar & Co. (FRN No. 100186W) reappointed as Joint Statutory Auditor for FY 2026-27
- M/s. J Singh & Associates (FRN No. 110266W) reappointed as Joint Statutory Auditor for FY 2026-27
SBI Life Insurance Company Limited announced its schedule to attend three institutional investor conferences in September 2026. Senior management is scheduled to participate in the UBS India Summit on September 11, the Jefferies India Forum on September 15–16, and the J.P. Morgan India Conference on September 22. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during these interactions. With a market cap of ₹1,72,278 crore and TTM revenue of ₹1,12,315 crore, this is a standard investor engagement update.
- Participating in UBS India Summit 2026 in Mumbai on September 11, 2026
- Attending Jefferies India Forum 2026 in Gurugram across September 15–16, 2026
- Scheduled for J.P. Morgan India Conference in Mumbai on September 22, 2026
- Company confirmed no unpublished price sensitive information will be shared
SBI Life Insurance Company Limited announced its schedule to participate in the Goldman Sachs Asia Leaders Conference 2026. The interaction is set to take place in Hong Kong on August 31, 2026, and September 01, 2026. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during these meetings.
- Participation in the Goldman Sachs Asia Leaders Conference 2026
- Meeting location: Hong Kong
- Scheduled dates: August 31, 2026, and September 01, 2026
- No unpublished price sensitive information (UPSI) to be shared
SBI Life Insurance Company Limited has informed the exchanges regarding its scheduled investor interaction. Senior management is scheduled to participate in the Morgan Stanley - India Financials Investor Group Trip in Mumbai on August 27, 2026. The company confirmed that no unpublished price sensitive information (UPSI) will be shared during the meeting.
- Conference: Morgan Stanley - India Financials Investor Group Trip
- Meeting Date: August 27, 2026
- Location: Mumbai
- No unpublished price sensitive information (UPSI) will be shared
SBI Life Insurance Company Limited announced that Mr. Narayan K. Seshadri ceased to be an Independent Director effective close of business hours on August 19, 2026. The cessation follows the successful completion of his tenure consisting of two consecutive terms of 3 years each (total 6 years). This is a standard corporate governance rotation in accordance with statutory term limits and has no operational or financial impact on the company.
- Cessation of Independent Director Mr. Narayan K. Seshadri effective close of business hours on August 19, 2026
- Completed statutory limit of two consecutive terms of 3 years each
- Filing made pursuant to Regulation 30 of SEBI LODR Regulations
SBI Life Insurance Company has approved the allotment of 88,522 equity shares of Rs. 10 each pursuant to the exercise of vested options under its Employee Stock Option Scheme 2018. Following this allotment on August 18, 2026, the company's total paid-up share capital stands at Rs. 10,03,34,95,720 divided into 100,33,49,572 equity shares. The allotment represents an insignificant equity dilution of less than 0.01% and is part of regular employee compensation operations.
- Allotted 88,522 equity shares of face value Rs. 10 each under ESOP Scheme 2018
- Post-allotment paid-up equity capital increased to Rs. 10,03,34,95,720
- Total post-allotment equity share count stands at 100,33,49,572 shares
- Allotment approved via Stakeholders' Relationship & Sustainability Committee resolution dated August 18, 2026
SBI Life Insurance Company Limited concluded its 26th Annual General Meeting on August 14, 2026, with all resolutions approved by the requisite majority. Shareholders adopted the FY26 financial statements and confirmed the interim dividend declared on February 25, 2026, as the final dividend. Additionally, the AGM approved the remuneration revision for MD & CEO Amit Jhingran and the fixation of Statutory Auditors' remuneration. The meeting saw participation from 81 shareholders through video conferencing.
- 26th AGM held on August 14, 2026, attended by 81 members via VC/OAVM
- Adoption of FY26 financial statements (FY26 Revenue: Rs 112,315 Cr, PAT: Rs 2,471 Cr)
- Confirmation of interim dividend declared on February 25, 2026 as final dividend for FY26
- Approved revision in remuneration of Managing Director & CEO Amit Jhingran
SBI Life Insurance Company Limited successfully conducted its 26th Annual General Meeting on August 14, 2026, with 81 members attending electronically. Shareholders approved the adoption of FY26 financial statements, where the company recorded annual revenue of ₹1,12,315 crore and net profit of ₹2,471 crore. The interim dividend declared on February 25, 2026, was confirmed as the final dividend for FY 2025-26. In addition, shareholders approved the remuneration framework for statutory auditors for FY 2026-27 and a revision in the remuneration of MD & CEO Mr. Amit Jhingran.
- 26th AGM concluded on August 14, 2026, with 81 shareholders attending via VC/OAVM
- Confirmed the interim dividend declared on February 25, 2026, as the final dividend for FY 2025-26
- Passed ordinary resolution revising the remuneration of MD & CEO Amit Jhingran
- All 4 ordinary and special business resolutions passed with the requisite majority
SBI Life Insurance Company Limited has scheduled a meeting with institutional investors and analysts at the Emkay Confluence Investor Conference in Mumbai on August 12, 2026. This is a standard regulatory disclosure under Regulation 30 of SEBI (LODR) Regulations. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during the interaction. Given the company's large market capitalization of Rs 1,86,153 Cr, such institutional engagements are routine.
- Investor meeting scheduled for August 12, 2026, in Mumbai.
- Conference hosted by Emkay Confluence Investor Conference.
- Company maintains a leading 24.6% market share in new business premium as of FY24/25.
- TTM Revenue for the company stands at Rs 1,12,315 Cr.
SBI Life reported a strong Q1 FY27 with Profit After Tax (PAT) rising 22% YoY to Rs 7.2 billion. Value of New Business (VNB) grew 29% to Rs 14.1 billion, supported by a 23% increase in New Business Premium (NBP) which reached Rs 89.1 billion. The VNB margin stood at 26.2%, which includes a Rs 2.3 billion GST impact; excluding this, the margin would have been 27.4%. The company maintained its leadership with a 22.2% private market share in individual rated new business premium.
- Value of New Business (VNB) grew 29% YoY to Rs 14.1 billion in Q1 FY27
- Profit After Tax (PAT) increased 22% YoY to Rs 7.2 billion
- New Business Premium (NBP) reached Rs 89.1 billion, representing 23% YoY growth
- Group protection APE saw a significant surge of 313% YoY to Rs 12.3 billion
- Solvency ratio remains robust at 1.96, well above the regulatory requirement of 1.5
SBI Life Insurance has released the audio recording of its earnings conference call for the first quarter of FY 2026-27, held on July 24, 2026. The call discussed the company's financial performance for the quarter ended June 30, 2026. This is a standard regulatory disclosure to ensure all investors have access to management's commentary and analyst interactions. The recording is available on the company's official investor relations website.
- Earnings call conducted on July 24, 2026, following Q1 results.
- Covers financial performance for the quarter ended June 30, 2026.
- Company leverages a distribution network of 27,500+ SBI branches.
- Management targets a growth rate of 15-17% as per company profile.
- Operating expense ratio remains best-in-class at 5.3% as of FY25.
Financial Performance
Revenue Growth by Segment
Gross Written Premium (GWP) grew 4.4% to INR 84,985 Cr in FY25 from INR 81,431 Cr in FY24. New Business Premium (NBP) grew 17% YoY to INR 183.5 billion in H1 FY26. Individual rated new business premium grew 7% to INR 86.8 billion in the same period. Non-SBI bank channels grew at 29% in Q1 FY26.
Geographic Revenue Split
The company has a presence across all states and union territories in India, leveraging 27,500+ SBI Group branches and 1,110 of its own offices as of March 31, 2025. Specific regional percentage splits are not disclosed, but the network provides 100% national coverage.
Profitability Margins
Value of New Business (VNB) margin stood at 27.8% in FY25, a slight compression from 28.1% in FY24 and 30.1% in FY23. Return on Equity (RoE) improved to 15.1% in FY25 from 13.6% in FY24. Profit After Tax (PAT) for FY25 was INR 2,413 Cr, a 27.4% increase from INR 1,894 Cr in FY24.
EBITDA Margin
Operating expense ratio is the lowest in the private sector at 5.3% of gross premiums in FY25. VNB grew 7% YoY to INR 5,950 Cr in FY25. Net profit margin is supported by high persistency, with the 61st-month ratio improving to 62.7% in FY25 from 58.6% in FY24.
Capital Expenditure
Planned expansion included opening 44 new branches and increasing employee count by over 3,500 in H1 FY26 to support a 15-17% growth aspiration. Absolute net worth increased to INR 16,793 Cr in FY25 from INR 14,591 Cr in FY24.
Credit Rating & Borrowing
CRISIL AAA/Stable rating maintained. The company has zero debt obligations on its balance sheet as of March 2025. Financial flexibility is high due to its listed status and 55.38% ownership by SBI.
Operational Drivers
Raw Materials
Not applicable for insurance services; primary 'inputs' are human capital (2.40 lakh agents) and financial capital (INR 16,793 Cr net worth).
Import Sources
Not applicable as the company provides financial services within India.
Key Suppliers
Not applicable; however, SBI acts as the primary corporate agent providing access to 27,500 branches.
Capacity Expansion
Current distribution capacity includes 2.40 lakh licensed agents (FY25) and 27,500 SBI branches. Planned expansion involves increasing agent productivity (currently INR 2.7 lakhs on individual NBP) and branch productivity (INR 4.6 million individual APE).
Raw Material Costs
Operating expenses increased due to the addition of 3,500+ employees and 44 new branches in H1 FY26. Commission expenses are linked to the 21% NBP contribution from the agency channel.
Manufacturing Efficiency
Operating expense ratio of 5.3% is the best-in-class among private insurers. 13th-month persistency of 87.4% in FY25 indicates high customer retention efficiency.
Logistics & Distribution
Bancassurance (SBI + RRBs) contributes 57% of total APE. Agency channel contributes 21% of NBP. Direct/Digital channels (including YONO) contribute to the remaining mix.
Strategic Growth
Expected Growth Rate
15-17%
Growth Strategy
Aggressive focus on the protection segment to exceed 10% of APE, leveraging GST reductions to lower consumer costs. Expansion of the agency force (10% gross addition in FY25) and tapping synergies with 27,500+ SBI branches for cross-selling.
Products & Services
Life insurance policies including Unit Linked Insurance Plans (ULIPs), Participating (PAR) products, Non-Participating (Non-PAR) savings products, and Protection/Term insurance.
Brand Portfolio
SBI Life
New Products/Services
New protection product lines for agency and banca channels, including digital-specific products for the YONO platform, aimed at increasing protection share to >10% of APE.
Market Expansion
Targeting increased penetration in rural and semi-urban areas via 27,500 SBI branches and 1,110 own offices. Focus on non-SBI banca partners which currently contribute only 3% of individual APE.
Market Share & Ranking
Ranked #1 among private life insurers with a 22.8% market share in individual rated premium and 24.6% in new business premium as of FY24/25.
Strategic Alliances
Joint venture between State Bank of India (55.38%) and public shareholders. Corporate agency tie-ups with Indian Bank, UCO Bank, South Indian Bank, Punjab & Sind Bank, and Yes Bank.
External Factors
Industry Trends
The industry is shifting toward protection and non-par savings. GST reduction on premiums is a major tailwind. Regulatory evolution regarding surrender values is forcing business model adjustments across the sector.
Competitive Landscape
Competes with HDFC Life, ICICI Prudential Life, and Max Life. SBI Life maintains the lead in private NBP market share at ~24.6%.
Competitive Moat
The primary moat is the exclusive access to SBI's 27,500+ branches and 500 million+ customer base, which ensures the lowest customer acquisition cost (5.3% OpEx ratio) in the industry. This is highly sustainable as long as SBI maintains a majority stake.
Macro Economic Sensitivity
Highly sensitive to Indian GDP growth and financial savings rates. Low insurance penetration in India provides a long-term structural tailwind for growth.
Consumer Behavior
Increasing financial awareness among the younger population is driving demand for protection products and digital-first insurance journeys.
Geopolitical Risks
Minimal direct impact as business is 100% domestic, though global market volatility affects the ULIP segment (46% of product mix).
Regulatory & Governance
Industry Regulations
Subject to IRDAI regulations. Must maintain a 1.5x solvency margin (currently 1.96x). Recent regulatory changes include revised surrender value norms and policy taxation limits.
Environmental Compliance
Not disclosed as a material cost; focus is on digital paperless processing.
Taxation Policy Impact
Recent GST reductions on insurance premiums are expected to specifically benefit the protection segment. Changes in the taxation of high-premium policies impact the Non-PAR and ULIP segments.
Legal Contingencies
Not specifically detailed in the documents, though the company faces inherent regulatory risks associated with the evolving Indian life insurance sector.
Risk Analysis
Key Uncertainties
Regulatory changes in surrender values could impact Embedded Value (EV) by 40-45 basis points. A decline in SBI's support or brand association would significantly impair distribution.
Geographic Concentration Risk
100% of revenue is from India, with a balanced distribution across all states via the SBI network.
Third Party Dependencies
57% dependency on SBI Group for APE business. Agency channel (21% NBP) acts as a secondary pillar.
Technology Obsolescence Risk
Risk is mitigated by integration with SBI's YONO platform and a focus on digital customer onboarding to match fintech competition.
Credit & Counterparty Risk
Investment portfolio is high quality with 86.9% in sovereign or AAA-rated instruments, minimizing counterparty default risk.